Positions

Professor
Medicine-Infectious Disease
Baylor College of Medicine
Houston, TX, US
Chief, Infectious Diseases Section
Michael E. DeBakey VAMC
Houston, Texas

Education

Fellowship at Baylor College Of Medicine
HIV Medicine
Clinical Fellowship at Baylor College Of Medicine
Infectious Diseases
Residency at Central University of Venezuela
Internal Medicine
MD from Central University Of Venezuela

Certifications

Board Certified
ABIM-Internal Medicine
Board Certified
ABIM-Infectious Diseases

Funding

1. Alcohol and multisubstance use in the veterans aging cohort study (Study within the Consortium to improve OutcoMes in HIV/AIDS, Alcohol, Aging, and multi-Substance use (COMpAAAS)
- #1-U01-AA-020790
Grant funding from NIH AAA
2. Integrated stepped care for unhealthy alcohol use in HIV. (Study within the Consortium to improve OutcoMes in HIV/AIDS, Alcohol, Aging, and multi-Substance use (COMpAAAS)
- #U01-AA020795
Grant funding from NIH AAA
4. Quantifying the burden of norovirus gastroenteritis in the Veterans Affairs Medical Center Patient Population
- #CDC 110FED1009332
Grant funding from CDC
5. The Respiratory Protection Effectiveness Clinical Trial (Respect). Funded by the VA National Center for Occupational Health and Infection Control
Grant funding from VA TDA Program-N1HA
Consortium to improve OutcoMes in HIV/AIDS, Alcohol, Aging, and multi-Substance use
- #(NIH AAA, U01AA020790)
Grant funding from Yale University
a. Observation Study: Veterans Aging Cohort Study: Survey and electronic cohort.
b. Integrated stepped care for unhealthy alcohol use in HIV.
c. Intervention Study: Financial Incentives, Randomization with Stepped Treatment (FIRST) trial.
d. Intervention Study: MASH Medication Reconciliation study (polypharmacy).
NOVVA
Grant funding from CDC
Active surveillance to quantify the burden of viral gastroenteritis and acute respiratory infections in US Veterans Affairs (VA) patient population. CDC contract. CDC PI: Cristina Cardemil and Kim Lindsay. Role: MEDVAMC PI.
Reprieve
Grant funding from NIH
REPRIEVE (A5332): Randomized trial to prevent vascular events in HIV. ACTG/NIH. Role: MEDVAMC PI
TRAP-LRTI
Grant funding from VTEU
5. TRAP-LRTI (Protocol 15-0020): Targeted reduction of antibiotics using procalcitonin in a multi-center randomized, blinded, placebo-controlled non-inferiority study of infection (LRTI) and a procalcitonin level of <0.1 ng/ml. 6/2016-6/2018. Baylor VTEU Protocol. Role: Houston PI.